Clinical Pharmacology Details


Verteporfin


View Drug Forms

Indications & Dose:

Photodynamic treatment of age related macular degeneration associated with predominantly classic subfoveal myopia, also for subfoveal neovascularisation with disease progression.


DOSAGE


Adult: By intravenous infusion over 10 minutes 6mg/ m2 

Contraindications:

Porphyria, breast-feeding. 

Side Effects:

Cautions:

Precautions:

Photosensitivity-avoid exposure of unprotected skin and eyes to bright light during infusion and for 24 hours afterwards; hepatic impairment, biliary obstruction; pregnancy. 

Interaction:

Warnings:

Adverse Effects:

Lactations:

Special Precautions:

Counselling:

Side Effects Or Adverse Reactions:

Visual disturbances, nausea, back pain, asthenia, pruritus, hypercholesterolaemia, fever rarly lacrimation disorder, subretinal or viterous haemorrhage, hypersensitivity reaction; injection site reactions including pain, oedema, inflamation, haemorrhage, discoloration

Patient And Carer Advice: